Symbol="ARVN"
AssetType="Common Stock"
Name="Arvinas Inc"
Description="Arvinas, Inc., a clinical-stage biopharmaceutical company, is dedicated to the discovery, development, and commercialization of therapies to break down disease-causing proteins. The company is headquartered in New Haven, Connecticut."
CIK="1655759"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="395 WINCHESTER AVE, 5 SCIENCE PARK, NEW HAVEN, CT, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="1290105000"
EBITDA="-287200000"
PERatio="None"
PEGRatio="None"
BookValue="9.57"
DividendPerShare="0"
DividendYield="0"
EPS="-5.94"
RevenuePerShareTTM="2.579"
ProfitMargin="-2.191"
OperatingMarginTTM="-2.134"
ReturnOnAssetsTTM="-0.138"
ReturnOnEquityTTM="-0.488"
RevenueTTM="137400000"
GrossProfitTTM="131400000"
DilutedEPSTTM="-5.94"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0.226"
AnalystTargetPrice="70.05"
TrailingPE="-"
ForwardPE="17.7"
PriceToSalesRatioTTM="17.64"
PriceToBookRatio="3.129"
EVToRevenue="6.07"
EVToEBITDA="-2.861"
Beta="1.756"
num_52WeekHigh="58.58"
num_52WeekLow="21.21"
num_50DayMovingAverage="24.73"
num_200DayMovingAverage="32.98"
SharesOutstanding="53398000"
DividendDate="None"
ExDividendDate="None"
symbol="ARVN"
open="24.74"
high="24.74"
low="24.11"
price="24.16"
volume="268663.00"
latest_trading_day="2023-07-14"
previous_close="24.63"
change="-0.47"
change_percent="-1.9082%"
aroon_positive_momentum_days="22"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="High Volatility / Hold Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="22"
Volume_recent_avg="454854"
Change_recent_avg="-0.14"
Delta_recent_avg="1.53"
Variance_recent_avg="0.77"
Change_ratio_recent_avg="-0.57"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="22"
Aroon_momentum_negative="78"
image_negative_thumbnail_id_1="125"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0051.jpeg"
image_negative_thumbnail_id_2="1136"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0169.jpeg"
image_neutral_thumbnail_id_1="548"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0051.jpeg"
image_neutral_thumbnail_id_2="593"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0006.jpeg"
image_positive_thumbnail_id_1="701"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0007.jpeg"
image_positive_thumbnail_id_2="652"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0056.jpeg"
image_professor_thumbnail_id_1="1172"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0006.jpeg"
image_professor_thumbnail_id_2="1204"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0038.jpeg"
